## FCX: Freeport-McMoRan, Inc. - XLB: Basic Materials

### Executive Summary

PARABOLIC warning: MRS_10 at 7.0% exceeds exhaustion threshold (8.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($45.11)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_10 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. FCX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Freeport-McMoRan Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!**
- Source: ConchoValleyHomepage.com | 20251209T120807 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE:FCX) for alleged violations of federal securities laws. The lawsuit claims that Freeport made false or misleading statements and failed to disclose inadequate safety measures at its Grasberg Block Cave mine in Indonesia, leading to heightened risks for workers and subsequent regulatory, litigation, and reputational damage. Investors who purchased Freeport securities between February 15, 2022, and September 24, 2025, are encouraged to join the lawsuit and have until January 12, 2026, to request to be appointed as lead plaintiff.

**2. Pomerantz LLP Notifies Investors of Class Action Against Freeport-McMoran Inc. â€“ FCX**
- Source: FOX40 News | 20251209T230835 | Neutral | Relevance: 99%
-  Pomerantz LLP has filed a class action lawsuit against Freeport-McMoran Inc. (NYSE:FCX), alleging securities fraud or unlawful business practices. Investors are encouraged to contact the firm to potentially become a Lead Plaintiff, with a deadline of January 12, 2026. The lawsuit stems from two incidents in September 2025 concerning the suspension of mining activities and subsequent worker fatalities at its Grasberg Block Cave operation, which led to significant drops in Freeport's stock price.

**3. INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Freeport-McMoran**
- Source: Morningstar | 20251211T151203 | Neutral | Relevance: 99%
-  Faruqi & Faruqi, LLP is investigating potential claims against Freeport-McMoran Inc. (NYSE: FCX) following alleged federal securities law violations. The lawsuit stems from statements made between February 15, 2022, and September 24, 2025, concerning safety at the Grasberg Block Cave mine in Indonesia, which reportedly led to worker fatalities and significant stock price drops. Investors who suffered losses and wish to lead the class action must do so by January 12, 2026.

**4. Levi & Korsinsky Moves to SueWallSt For Freeport-McMoRan Inc. Investors That Lost Money**
- Source: WJBF | 20251209T230826 | Neutral | Relevance: 99%
-  Levi & Korsinsky has filed a class action lawsuit against Freeport-McMoRan Inc. on behalf of investors who reportedly lost money due to alleged securities fraud between February 15, 2022, and September 24, 2025. The firm encourages affected investors to contact them for more information regarding the lawsuit. This action aims to recover losses for aggrieved shareholders.

**5. FCX SHAREHOLDER NEWS: Did Freeport-McMoRan Inc. Mislead Investors? Contact BFA Law about the Ongoing Securities Class Action by January 12 Deadline**
- Source: Fox 59 | 20251209T200855 | Neutral | Relevance: 99%
- Bleichmar Fonti & Auld LLP (BFA Law) has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) and its executives for alleged securities fraud. The lawsuit claims Freeport-McMoRan misled investors about its safety practices, leading to significant stock drops after fatal incidents and operational suspensions at its Grasberg mine in Indonesia. Investors who purchased Freeport securities have until January 12, 2026, to seek appointment as lead plaintiff in the case.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |
| 2025-11-19 | Scotiabank | $47 | $51 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-19 | Scotiabank | up | Sector Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 3.0x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +2.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.98 signals overvaluation risk, limited margin of safety. Forward P/E 22.3x attractive for 42% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 1 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $69.1B |
| Beta | 1.48 |
| 52W Range | $27.66 - $49.12 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.98 |
| Forward P/E | 22.3 |
| Current P/E | 31.6 |
| YoY Growth | 41.6% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from 4.1% to 7.0% (+2.9% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (7.0% > 6.0%), caution on chasing. MRS_5 at 4.8% confirms short-term momentum alignment. Outperforming sector by 6.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.58), confirming momentum. RSI overbought at 74, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 7.02% (CS: 95) | Strong |
| RSI_14 | 74.2 | Overbought |
| MACD Histogram | 0.58 | Bullish |
| vs SMA20 | 1.129x | Above |
| vs SMA50 | 1.153x | Above |
| vs SMA200 | 1.182x | Above |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $48.11
- **Stop Loss:** $45.11 (6.2% risk)
- **Target:** $51.11 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 460
- **Position Value:** $22,130.60
- **Portfolio %:** 22.13%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*